Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Double-Blind Trial Of Targretin Capsules Modifying Immunophenotypic Markers Related To Breast Cancer Progression In Breast Tissue From Genetically Identified High Risk Patients

NCT00055991 is registered in ClinicalTrials.gov with Baylor Breast Care Center as lead sponsor.

NCT NCT00055991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00055991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Double-Blind Trial Of Targretin Capsules Modifying Immunophenotypic Markers Related To Breast Cancer Progression In Breast Tissue From Genetically Identified High Risk Patients
Lead sponsor
Baylor Breast Care Center
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2001
Completion date
September 30, 2006
Enrollment
87 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer